These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15913112)

  • 21. Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression.
    Lin X; Robinson NJ; Thursz M; Rosenberg DM; Weild A; Pimenta JM; Hall AJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):833-43. PubMed ID: 15946129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling and calibration of the hepatitis C epidemic in Australia.
    Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
    Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus and glucose and lipid metabolism.
    Alaei M; Negro F
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):692-700. PubMed ID: 19195632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The global impact of hepatic fibrosis and end-stage liver disease.
    Lim YS; Kim WR
    Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
    Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
    J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: chronic hepatitis C--natural history and cofactors.
    Alberti A; Vario A; Ferrari A; Pistis R
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():74-8. PubMed ID: 16225479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Natural history of hepatitis C virus infection].
    Marcellin P; Benhamou JP
    Pathol Biol (Paris); 1995 Oct; 43(8):669-73. PubMed ID: 8745588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.
    Santantonio T; Medda E; Ferrari C; Fabris P; Cariti G; Massari M; Babudieri S; Toti M; Francavilla R; Ancarani F; Antonucci G; Scotto G; Di Marco V; Pastore G; Stroffolini T
    Clin Infect Dis; 2006 Nov; 43(9):1154-9. PubMed ID: 17029134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of hepatitis C virus infection in Pakistan.
    Raja NS; Janjua KA
    J Microbiol Immunol Infect; 2008 Feb; 41(1):4-8. PubMed ID: 18327420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and risk factors for hepatitis C virus infection in Mongolian children: Findings from a nationwide survey.
    Davaalkham D; Ojima T; Nymadawa P; Uehara R; Watanabe M; Oki I; Nakamura Y
    J Med Virol; 2006 Apr; 78(4):466-72. PubMed ID: 16482536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural history and predictors of disease severity in chronic hepatitis C.
    Massard J; Ratziu V; Thabut D; Moussalli J; Lebray P; Benhamou Y; Poynard T
    J Hepatol; 2006; 44(1 Suppl):S19-24. PubMed ID: 16356583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma and non-Hodgkin's lymphoma: the roles of HIV, hepatitis C infection, and alcohol abuse.
    McGinnis KA; Fultz SL; Skanderson M; Conigliaro J; Bryant K; Justice AC
    J Clin Oncol; 2006 Nov; 24(31):5005-9. PubMed ID: 17075119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steatosis in hepatitis C virus infection. Response to anti-viral therapy.
    Szanto P; Grigorescu M; Dumitru I; Serban A
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):117-24. PubMed ID: 16802005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Natural history of hepatitis C virus infection].
    Uriz J; Briz R
    An Sist Sanit Navar; 2004; 27 Suppl 2():51-8. PubMed ID: 15381943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C--clinical profile.
    Bhandari B; Pal A
    J Indian Med Assoc; 2007 Aug; 105(8):453-4, 456, 465. PubMed ID: 18236909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progression to cirrhosis in hepatitis C patients: an age-dependent process.
    Pradat P; Voirin N; Tillmann HL; Chevallier M; Trépo C
    Liver Int; 2007 Apr; 27(3):335-9. PubMed ID: 17355454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of hepatocellular carcinoma complicating chronic hepatitis C.
    Ueno Y; Sollano JD; Farrell GC
    J Gastroenterol Hepatol; 2009 Apr; 24(4):531-6. PubMed ID: 19368633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.